Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Allscripts Hlthcare (MDRX)

Allscripts Hlthcare (MDRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,790,897
  • Shares Outstanding, K 162,366
  • Annual Sales, $ 1,750 M
  • Annual Income, $ 412,330 K
  • 60-Month Beta 1.39
  • Price/Sales 1.04
  • Price/Cash Flow 6.43
  • Price/Book 1.47

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate 0.15
  • Number of Estimates 9
  • High Estimate 0.17
  • Low Estimate 0.13
  • Prior Year 0.16
  • Growth Rate Est. (year over year) -6.25%

Price Performance

See More
Period Period Low Period High Performance
1-Month
10.22 +6.26%
on 10/15/19
11.82 -8.12%
on 11/05/19
+0.27 (+2.55%)
since 10/11/19
3-Month
8.75 +24.11%
on 08/15/19
11.82 -8.12%
on 11/05/19
+1.22 (+12.66%)
since 08/12/19
52-Week
8.54 +27.17%
on 12/26/18
12.40 -12.42%
on 02/19/19
+0.70 (+6.89%)
since 11/12/18

Most Recent Stories

More News
Pulse8 Presenting as a Panelist on Provider-Health Plan Relationships During the RISE Risk Adjustment Forum in Scottsdale, AZ

In its 14th year, the annual RISE Risk Adjustment Forum acts as a resource for health professionals seeking expert knowledge and continuous improvements to risk adjustment programs from experienced industry...

MDRX : 10.86 (-1.54%)
MDRX or TRHC: Which Is the Better Value Stock Right Now?

MDRX vs. TRHC: Which Stock Is the Better Value Option?

MDRX : 10.86 (-1.54%)
TRHC : 40.53 (-3.82%)
Allscripts (MDRX) Q3 Earnings Beat Estimates, Improve Y/Y

Allscripts (MDRX) third-quarter results gain from growth in bookings and solid segmental performance. Contraction in both gross and operating margins remains a woe.

MDRX : 10.86 (-1.54%)
TMO : 295.95 (+0.82%)
EW : 239.64 (+2.10%)
RMD : 144.09 (+0.15%)
AllScripts Healthcare (MDRX) Beats Q3 Earnings Estimates

AllScripts (MDRX) delivered earnings and revenue surprises of 6.25% and -1.20%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

MDRX : 10.86 (-1.54%)
AllScripts: 3Q Earnings Snapshot

CHICAGO (AP) _ Allscripts Healthcare Solutions Inc. (MDRX) on Monday reported a loss of $5.7 million in its third quarter.

MDRX : 10.86 (-1.54%)
Allscripts Announces Third Quarter 2019 Results

Allscripts Healthcare Solutions, Inc. (Nasdaq: MDRX) (Allscripts) announced its financial results for the three and nine months ended September 30, 2019.

MDRX : 10.86 (-1.54%)
AllScripts Healthcare (MDRX) Expected to Beat Earnings Estimates: Should You Buy?

AllScripts (MDRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

MDRX : 10.86 (-1.54%)
Allscripts to release third-quarter 2019 financial results November 4

Allscripts Healthcare Solutions, Inc. (Nasdaq:MDRX) will report its financial results for the three months ended September 30, 2019, after the close of stock market hours on Monday, November 4, 2019. Allscripts...

MDRX : 10.86 (-1.54%)
Allscripts Healt Shares Up 4.1% Since SmarTrend's Buy Recommendation (MDRX)

SmarTrend identified an Uptrend for Allscripts Healt (NASDAQ:MDRX) on September 12th, 2019 at $10.32. In approximately 1 month, Allscripts Healt has returned 4.07% as of today's recent price of $10.74....

MDRX : 10.86 (-1.54%)
Here's Why You Should Add Allscripts to Your Portfolio Now

Allscripts' (MDRX) focus on innovation makes it a worthy investment pick.

MDRX : 10.86 (-1.54%)
SAUHF : 903.8000 (+1.02%)
MCK : 145.63 (+3.77%)
NNCHY : 39.5900 (-2.92%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Soft. Long term indicators fully support a continuation of the trend.

See More Share

Trade MDRX with:

Business Summary

Allscripts Healthcare Solutions, Inc. offers clinical software, services, information and connectivity solutions that enable physicians and healthcare providers to deliver patients safety and clinical outcomes in the US. The Company provides intuitive clinical and business solutions including Electronic...

See More

Key Turning Points

2nd Resistance Point 11.26
1st Resistance Point 11.15
Last Price 10.86
1st Support Level 10.91
2nd Support Level 10.78

See More

52-Week High 12.40
Fibonacci 61.8% 10.93
Last Price 10.86
Fibonacci 50% 10.47
Fibonacci 38.2% 10.01
52-Week Low 8.54

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar